Side Effects of Doxorubicin

When side effects of doxorubicin occur, they are usually minor and easily treated. Some of the most common doxorubicin side effects include hair loss, vomiting, and weight gain. However, a number of side effects with doxorubicin are more serious and should be reported immediately to a healthcare provider. Among these serious side effects are blood in the stool, difficulty breathing, and seizures.

An Introduction to Side Effects of Doxorubicin

As with any medicine, side effects are possible with doxorubicin hydrochloride (Adriamycin®, Doxil®). However, not everyone who takes the medication will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are easily treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with doxorubicin. Your healthcare provider can discuss a more complete list of doxorubicin side effects with you.)
 

Common Side Effects of Doxorubicin

Doxorubicin has been studied thoroughly in clinical trials, in which the side effects of a group of people taking the drug are documented. In these studies, the most common side effects of doxorubicin when it was used in combination with cyclophosphamide (Cytoxan®, Neosar®) included:
 
  • Hair loss -- in up to 92 percent of people (see Doxorubicin and Hair Loss)
  • Vomiting -- up to 71.2 percent
  • Nausea (without vomiting) -- up to 15.5 percent (see Chemotherapy and Nausea)
  • Weight gain -- up to 14.4 percent (see Doxorubicin and Weight Gain)
  • Weight loss -- up to 8.6 percent
  • Leukopenia (low levels of certain white blood cells called leukocytes) -- up to 3.7 percent.
  •  
Doxorubicin often causes discoloration of the urine, which may look like blood in your urine. However, this is normal and is not dangerous.
 
(Side Effects of Doxorubicin Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation